:::

詳目顯示

回上一頁
題名:A Minireview of ADHD Pharmacotherapy
書刊名:Taiwanese Journal of Psychiatry
作者:張勝傑
作者(外文):Chang, Shen-chieh
出版日期:2014
卷期:28:4
頁次:頁207-210
主題關鍵詞:過動症藥物治療
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:4
期刊論文
1.The MTA cooperative group(1999)。The MTA cooperative group A 14-month randomized clinical trial of treatment strategies for attentiondefi cit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD。Arch Gen Psychiatry,56,1073-1086。  new window
2.Subcommittee on Attention-Defi cit/Hyperactivity Disorder(2011)。Steering Committee on Quality Improvement and Management. Wolraich M, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-defi cit/hyperactivity disorder in children and adolescents。Pediatrics,128,1007-1022。  new window
3.Marcus, S. C.、Wan, G. J.、Kemner, J. E.、Olfson, M.(2005)。Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder。Arch Pediatr Adolesc Med,159,572-578。  new window
4.Pliszka, S. R.、Crismon, M. L.、Hughes, C. W.(2006)。Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Defi cit Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder。J Am Acad Child Adolesc Psychiatry,45,642-657。  new window
5.Childress, A. C.、Sallee, F. R.(2014)。Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management。CNS Drugs,28,121-129。  new window
6.Koda, K.、Ago, Y.、Cong, Y.、Kita, Y.、Takuma, K.、Matsuda, T.(2010)。Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice。J Neurochem,114,259-270。  new window
7.Garnock-Jones, K. P.、Keating, G. M.(2009)。Atomoxetine: a review of its use in attention-defi cit hyperactivity disorder in children and adolescents。Paed Drugs,11,203-226。  new window
8.Scahill, L.(2009)。Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness。CNS Drugs,23(Suppl 1),43-49。  new window
9.Arnsten, A. F.(2010)。The use of α-2A adrenergic agonists for the treatment of attention-defi cit/hyperactivity disorder。Expert Rev Neurother,10,1595-1605。  new window
10.Hirota, T.、Schwartz, S.、Correll, C. U.(2014)。Alpha-2 agonists for attention-defi cit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy。J Am Acad Child Adolesc Psychiatry,53,153-173。  new window
11.Maneeton, N.、Maneeton, B.、Intaprasert, S.、Woottiluk, P.(2014)。A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder。Neuropsychiatr Dis Treat,10,1439-1449。  new window
12.Otasowie, J.、Castells, X.、Ehimare, U. P.、Smith, C. H.(2014)。Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents。The Cochrane database of systematic reviews,9。  new window
13.Park, P.、Caballero, J.、Omidian, H.(2014)。Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-defi cit hyperactivity disorder in pediatrics。Ann Pharmacother,48,86-92。  new window
14.Kumar, R.(2008)。Approved and investigational uses of modafi nil: an evidence-based review。Drugs,68,1803-1839。  new window
15.Pliszka, S.(2007)。Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder。J Am Acad Child Adolesc Psychiatry,46,894-921。  new window
圖書
1.Sadock, B. J.、Sadock, V. A.、Ruiz, P.(2014)。Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry。Philadelphia:Lippincott Williams & Wilkins。  new window
2.Stahl, S. M.(2013)。Attention-deficit/hyperactivity disorder. In: Stahl SM: Stahl's Essential Psychopharmacology。New York:Cambridge University Press。  new window
3.Potter, A. S.、Schaubhut, G.、Shipman, M.。Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date。CNS Drugs。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE